Why in news
- The Department of Pharmaceuticals has extended the Production Linked Incentive Scheme for Medical Devices (PLI-MD) up to FY 2035–36 and invited fresh applications.
- Operational guidelines were modified to eliminate minimum sales thresholds and reduce investment requirements to improve ease of doing business.
Key terms
A financial incentive scheme offering performance-linked rewards based on incremental sales from domestic production.
Classified categories of medical equipment and components designated for specific financial incentives.
A mandatory revenue baseline previously required before an applicant could qualify to receive incentive payouts.
The administrative body under the Ministry of Chemicals and Fertilizers managing pharmaceutical and medical device manufacturing policies.
What is the PLI-MD Scheme?
- Launched in FY 2020–21 by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, to promote domestic manufacturing of medical devices and reduce import dependence.
- Covers four Target Segments: medical consumables/disposables/implants (TS 1), critical components (TS 2), high-end devices at nascent stages (TS 3), and assembled high-end devices (TS 4).
Key operational changes
- Scheme tenure extended up to FY 2035–36 with an available outlay of approximately Rs 2,700 crore.
- Minimum Sales Threshold requirement to claim incentives has been completely discontinued.
- Minimum Investment Requirement trimmed to lower capital entry barriers for component manufacturers.
- Applicants allowed a baseline gestation period of 3 years for establishing manufacturing facilities across all target segments.
Why it matters
- Shifts policy focus from finished equipment assembly to local critical component manufacturing (such as X-ray tubes, MRI magnets, LINAC components).
- Improves viability for domestic med-tech MSMEs by decoupling financial disbursements from mandatory revenue milestones.
Prelims facts
- PLI-MD covers 4 target segments ranging from consumables to critical component manufacturing.
- Minimum sales threshold requirement for claiming incentive under PLI-MD has been removed.
Mains discussion
- Role of targeted production incentives in curbing critical medical equipment import dependence.
- Impact of simplifying compliance norms on boosting capital investment in domestic med-tech research and development.
Source: PIB
समान विषय · पिछले पेपर
UPSC ने यह पहले भी पूछा है
ये पिछले वर्षों के प्रश्न उसी विषय पर हैं। अभ्यास के लिए खोलें।
-
2022 · Q37 · General Studies · 2 marks
Consider the following statements: 1. Biofilms can form on medical implants within human tissues. 2. Biofilms can form on food and food processing surfaces. 3. Biofilms can exhibit antibiotic resistance. Which of the statements given above are correct? -
2017 · Q6 · GS III · 10 marks
Stem cell therapy is gaining popularity in India to treat a wide variety of medical conditions including leukaemia, Thallessemia, damaged sornea and several burns. Describe briefly what stem cell therapy is and what advantages it has over other treatments? -
2016 · Q34 · General Studies · 2 marks
With reference to pre-packaged items in India, it is mandatory for the manufacturer to put which of the following information on the main label, as per the Food Safety and Standards (Packaging and Labelling) Regulations, 2011? 1. List of ingredients including additives 2. Nutrition information 3. Recommendation, if any, made by the medical profession about the possibility of any allergic reactions 4. Vegetarian/non-vegetarian Select the correct answer using the code given below -
2022 · Q33 · General Studies · 2 marks
With reference to "Software as a Service (SaaS)", consider the following statements: 1. SaaS buyers can customise the user interface and can change data fields. 2. SaaS users can access their data through their mobile devices. 3. Outlook, Hotmail and Yahoo! Mail are forms of SaaS. Which of the statements given above are correct? -
2022 · Q36 · General Studies · 2 marks
Consider the following communication technologies: 1. Closed-circuit Television 2. Radio Frequency Identification 3. Wireless Local Area Network Which of the above are considered Short Range devices/technologies?